Pay in installments of $43.75 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jun 21 - Jun 26
For Your Every Summer RSVP, with Code: SUMMER15
Description
Helixor: Viscosan A Series II - 7 vialsEuropean mistletoe (Viscum album) is one of the worlds oldest medicinal plants, used since the time of Hippocrates. Today, more than 150 clinical studies have proven its efficacy and safety. This makes it a well studied and frequently used therapy in integrative medicine. Each ampoule of Viscosan contains: a dilution of Viscum album mother tincture, sodium chloride, sodium hydroxide, and sterile water. Since 1975, Helixor has been a leading

Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 903 reviews
Sort
Product Reviews
★★★★★ 5
Great product
Color: Black
long-lasting and gets the job done.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 19, 2025
★★★★★ 5
Works for us.
Color: Black
F170 - no issue and not expired (which was my only concern).
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 16, 2026
★★★★★ 5
Quality ink
Color: Complete Set
😊
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 14, 2025
★★★★★ 5
Perfect
Color: Black
It arrived super fast and in perfect condition.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 18, 2026
★★★★★ 5
Original
Color: Black
Entrega rápida y producto original
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 14, 2026




